Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
RNA Editing02:23

RNA Editing

9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative reconstruction and sedimentary response of a Jurassic paleodrainage system.

Scientific reports·2026
Same author

Association Between Plasma Fibrinogen Level and the Risk of Myocardial Infarction With Non-Obstructive Coronary Arteries: A Retrospective Observational Study.

Reviews in cardiovascular medicine·2026
Same author

ZnO Nanostructure-Based Flexible Pressure Sensors Deposited on Filter Paper for Wearable Application.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Superhydrophobic and environmentally friendly bovine bone biomass based cellulose membrane for oil-water separation.

International journal of biological macromolecules·2024
Same author

Circular RNAs in atrial fibrillation: From bioinformatics analysis of circRNA-miRNA-mRNA network to serum expression.

Biochemistry and biophysics reports·2023
Same author

The prognostic value of systemic vascular resistance in heart failure patients with permanent atrial fibrillation: a retrospective study.

Heart and vessels·2023

Related Experiment Video

Updated: Jul 20, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.7K

Research progress of non-coding RNA in atrial fibrillation.

Zongqian Xue1, Jinbiao Zhu1, Juan Liu1

  • 1Department of Cardiology, Aoyang Hospital Affiliated to Jiangsu University, Zhangjiagang, China.

Frontiers in Cardiovascular Medicine
|July 31, 2023
PubMed
Summary

Atrial fibrillation (AF) is a growing health concern, especially with an aging population. Research into non-coding RNAs (ncRNAs) may offer new diagnostic markers and targeted therapies for this common heart rhythm disorder.

Keywords:
atrial fibrillationbiomarkerdiagnosisexosomencRNAs

More Related Videos

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

2.8K
Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

3.2K

Related Experiment Videos

Last Updated: Jul 20, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.7K
Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

2.8K
Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

3.2K

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Atrial fibrillation (AF) is a prevalent cardiac arrhythmia with increasing incidence, particularly in aging populations.
  • AF significantly impacts patient quality of life and can lead to severe complications like thrombosis and heart failure.
  • Current diagnostic and therapeutic strategies for AF lack specific serum markers and targeted treatments.

Purpose of the Study:

  • To explore the role of non-coding RNAs (ncRNAs) in the pathophysiology of atrial fibrillation.
  • To identify potential ncRNA biomarkers for AF diagnosis.
  • To investigate ncRNAs as targets for novel AF therapies.

Main Methods:

  • Review of current literature on ncRNAs in cardiovascular diseases.
  • Analysis of studies investigating ncRNA involvement in AF development and progression.
  • Exploration of ncRNAs in other cardiovascular conditions like myocardial infarction and atherosclerosis.

Main Results:

  • ncRNAs are implicated in the occurrence and development of AF.
  • ncRNAs play roles in the pathophysiological processes of myocardial infarction and atherosclerosis.
  • ncRNAs show potential as biomarkers for cardiovascular diseases, including AF.

Conclusions:

  • Understanding the pathophysiological mechanisms of AF involving ncRNAs is crucial.
  • ncRNAs represent promising targets for the development of specific diagnostic markers and targeted therapies for AF.
  • Further research into ncRNAs can lead to a more systematic diagnostic and treatment framework for atrial fibrillation.